Sigma-Aldrich (Shanghai) Trading: difference between revisions
Diff·revision 5 → 6·14:17, 21 May 2025
Difference between revision 5 and revision 6 of Sigma-Aldrich (Shanghai) Trading. 10 lines changed; the page grew by 2,296 bytes.
| Revision 5 — 16:18, 9 May 2025 NNT_Nerys (talk) add the lead time for catalogue lines, as reported 3,939 bytes +976 | Revision 6 — 14:17, 21 May 2025 BlankVialBo (talk) correct the trading name — the short code and the legal name are different things 6,235 bytes +2,296 | ||
|---|---|---|---|
| 10 | The organisation is one of twenty-eight covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}} | 10 | The organisation is one of twenty-eight covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}} |
| 11 | 11 | ||
| + | 12 | This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by [[Janoshik Analytical]], [[Medutest]], [[PeptideMeter]] and [[VendorInvestigate]].{{r|tally}} | |
| + | 13 | ||
| 12 | == Corporate identity and history == | 14 | == Corporate identity and history == |
| 13 | Incorporated in Shanghai in 2005 and registered in the Pudong New Area, the organisation trades as a distributor rather than as a manufacturer.{{r|registry}} Its own material describes a business built on supplying research-grade compounds against a written specification of its own, with synthesis performed by parties it does not name.{{r|selfpub}} | 15 | Incorporated in Shanghai in 2005 and registered in the Pudong New Area, the organisation trades as a distributor rather than as a manufacturer.{{r|registry}} Its own material describes a business built on supplying research-grade compounds against a written specification of its own, with synthesis performed by parties it does not name.{{r|selfpub}} |
| ⋮ | ⋮ | ||
| 20 | The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report. | 22 | The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report. |
| 21 | 23 | ||
| + | 24 | == Operations and documentation practice == | |
| + | 25 | Purchaser reports describe vialled lyophilised material arriving with a batch-specific [[Certificate of analysis|certificate]] naming a [[Batch number|lot]], and across the submitted set the lot string on the certificate has corresponded to the vial label and to the invoice.{{r|reports}} That correspondence is a minimum requirement rather than an achievement, and it is recorded only because [[Lot traceability|traceability]] fails often enough elsewhere in this sector to make its absence the more common finding. | |
| + | 26 | ||
| + | 27 | Two documentary practices recur across the submitted set and are the most useful observations available about this organisation. Related substances are reported as an itemised table with retention times rather than as a single aggregate figure, which lets a reader distinguish a profile dominated by one impurity from a diffuse profile of the same magnitude. A stability statement tied to a named storage condition appears on the certificates described across most of the set; a shelf-life statement without a stated condition cannot be checked, and one with a condition can.{{r|reports,usp1503}} | |
| + | 28 | ||
| 22 | == References == | 29 | == References == |
| 23 | {{reflist}} | 30 | {{reflist}} |
| 24 | <ref name="registry">National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.</ref> | 31 | <ref name="registry">National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.</ref> |
| 25 | <ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref> | 32 | <ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref> |
| + | 33 | <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> | |
| + | 34 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | |
| + | 35 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.</ref> | |
| 26 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 36 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| 27 | 37 |